Technical Analysis for RPHM - Reneo Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 8.67 -1.70% -0.15
RPHM closed down 1.7 percent on Wednesday, July 28, 2021, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical RPHM trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -1.70%
Fell Below 20 DMA Bearish -2.25%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.25%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.93%
Crossed Above 20 DMA Bullish -4.93%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.58%
Inside Day Range Contraction -2.58%
MACD Bullish Signal Line Cross Bullish -2.36%
Older End-of-Day Signals for RPHM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Possible Inside Day about 15 hours ago
Possible NR7 about 15 hours ago
Down 2 % about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Industry Clinical Research Clinical Trial Stage Pharmaceutical Transcription Factors Carboxylic Acids Intracellular Receptors

Is RPHM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.1799
52 Week Low 7.63
Average Volume 64,509
200-Day Moving Average 0.00
50-Day Moving Average 9.42
20-Day Moving Average 8.91
10-Day Moving Average 8.77
Average True Range 0.61
ADX 9.81
+DI 21.82
-DI 21.01
Chandelier Exit (Long, 3 ATRs) 7.96
Chandelier Exit (Short, 3 ATRs) 10.08
Upper Bollinger Bands 9.51
Lower Bollinger Band 8.30
Percent B (%b) 0.3
BandWidth 13.51
MACD Line -0.25
MACD Signal Line -0.31
MACD Histogram 0.0564
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.18
Resistance 3 (R3) 9.18 9.00 9.10
Resistance 2 (R2) 9.00 8.87 9.01 9.07
Resistance 1 (R1) 8.84 8.79 8.75 8.84 9.04
Pivot Point 8.66 8.66 8.62 8.67 8.66
Support 1 (S1) 8.50 8.53 8.41 8.50 8.30
Support 2 (S2) 8.32 8.45 8.33 8.27
Support 3 (S3) 8.16 8.32 8.25
Support 4 (S4) 8.16